|
Case
| HBS Case Collection
|
1993
Genzyme Corporation: A Financing History
by
Timothy A. Luehrman and Andrew D. Regan
|
Abstract
Genzyme Corp.'s financing history is unusual compared to most biotech companies. This case presents the sequence of financings employed by Genzyme, along with the product--market and corporate-development strategies adopted by Henri Termeer, Genzyme's CEO. As such, the case permits students to evaluate the sequence of financings as a "program" rather than a series of unrelated deals and to consider them in light of the business strategy.
Keywords: History;
Financing and Loans;
Business Strategy;
Growth and Development Strategy;
Biotechnology Industry;